Muramatsu M, Tanaka M, Suwa T, Fujita A, Otomo S, Aihara H
Biochem Pharmacol. 1984 Aug 15;33(16):2629-33. doi: 10.1016/0006-2952(84)90636-1.
SU-88 [2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone] inhibited the activity of the prostaglandin (PG)-metabolizing enzyme, 15-hydroxy-PG-dehydrogenase (15-OH-PG-DH), in a cytoplasmic fraction of gastric mucosa. This compound had no effect on the PG synthetase of bovine seminal vesicle microsomes and lactate dehydrogenase in rat liver. The 15-OH-PG-DH activity of gastric mucosa was not influenced by a specific inhibitor of alcohol dehydrogenase, 4-methylpyrazole. Carbenoxolone (CBX) also inhibited 15-OH-PG-DH activity. The IC50 values for SU-88 and CBX were approximately 20 and 40 microM respectively. SU-88 inhibited 15-OH-PG-DH activity uncompetitively or competitively according to whether PGE1 or NAD was used as substrate. CBX inhibited competitively the activity of this enzyme for both substrates. After the addition of SU-88 or CBX to the incubation medium of gastric mucosa, the PGE2 level of the medium was increased significantly while that of the tissue remained unchanged. These results indicate that SU-88 specifically inhibited 15-OH-PG-DH activity and suggest that 15-OH-PG-DH activity regulates the level of PGs in gastric mucosa and may have an anti-ulcer influence.
SU - 88[2'-羧基甲氧基 - 4,4'-双(3 - 甲基 - 2 - 丁烯氧基)查耳酮]抑制胃黏膜细胞质部分中前列腺素(PG)代谢酶15 - 羟基 - PG - 脱氢酶(15 - OH - PG - DH)的活性。该化合物对牛精囊微粒体的PG合成酶和大鼠肝脏中的乳酸脱氢酶没有影响。胃黏膜的15 - OH - PG - DH活性不受乙醇脱氢酶特异性抑制剂4 - 甲基吡唑的影响。生胃酮(CBX)也抑制15 - OH - PG - DH活性。SU - 88和CBX的IC50值分别约为20和40微摩尔。根据使用PGE1还是NAD作为底物,SU - 88以非竞争性或竞争性方式抑制15 - OH - PG - DH活性。CBX对两种底物均竞争性抑制该酶的活性。在向胃黏膜孵育培养基中加入SU - 88或CBX后,培养基中PGE2水平显著升高,而组织中的PGE2水平保持不变。这些结果表明SU - 88特异性抑制1